Hostname: page-component-848d4c4894-4rdrl Total loading time: 0 Render date: 2024-07-02T02:20:18.322Z Has data issue: false hasContentIssue false

The Effect of Fluphenazine Enanthate on Chronic and Relapsing Schizophrenia

Published online by Cambridge University Press:  29 January 2018

John Lowther*
Affiliation:
City of Cardiff Public Health Department, Greyfriars Road, Cardiff (St. Cadoc's Hospital, Caerleon, Monmouthshire)

Extract

Since Delay and Deniker's (1) report on the efficacy of chlorpromazine, phenothiazines have become the cornerstone of treatment for schizophrenia. However, the unreliability of patients in taking oral drugs is a major disadvantage which the introduction of fluphenazine enanthate has helped to remedy.

Type
Pharmacotherapy
Copyright
Copyright © Royal College of Psychiatrists, 1969 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Delay, J., and Deniker, P. (1952). Ann. méd-psychol., 110, 112.Google Scholar
2. Goldberg, S. C., Matson, N., Cole, J. O., and Klerman, G. L. (1967). Arch. gen. Psychiat. (Chic.), 16, 107.Google Scholar
3. Millar, J., and Daniel, G. R. (1967). Brit. J. Psychiat., 113, 1431.Google Scholar
4. Ayd, F. J. (1961). J. Amer. med. Ass., 175, 1054.Google Scholar
5. Hunter, R., Earl, C., and Janz, D. (1964). J. Neurol. Neurosurg. Psychiat., 27, 219.Google Scholar
6. Faurbyre, A., Rasch, P. J., Peterson, P. B., Brandborg, G., and Pakkenberg, H. (1964). Acta psychiat. Scand., 40, 10.Google Scholar
7. Kline, N. S. (1968). Amer. J. Psychiat., 124, 48.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.